Clinical Genomics Technologies Pty Ltd.
Bridgewater, NJ, US
Small Business (1-10M TTM Revenue)
At Clinical Genomics, we harness breakthrough science to create innovative and accessible ways to detect disease and enhance lives.
Clinical Genomics is a privately held biotechnology company developing and marketing innovative products for colorectal cancer (CRC) diagnosis. With a broad intellectual property portfolio consisting of more than 95 patents, Clinical Genomics sells colorectal cancer screening and monitoring solutions. In 2016, Clinical Genomics launched Colvera™, a sensitive and specific blood-based circulating tumor DNA (ctDNA) test for colorectal cancer recurrence monitoring that detects methylated DNA from two genes, BCAT1 and IKZF1. Via its wholly-owned subsidiary Enterix Inc., the company offers the user-friendly, patient-preferred colorectal cancer screening InSure® FIT™ assay, an FDA-cleared fecal immunochemical test that detects blood in the stool.
Clinical Genomics has offices and CLIA-registered laboratories in Bridgewater as well as FDA-registered and TGA-licensed IVD manufacturing in Edison, New Jersey and Sydney, Australia and a NATA-accredited laboratory in North Ryde, NSW Australia.
|Clinical Genomics Technologies Pty Ltd. 1031 US Highway 202/206, Suite 100 Bridgewater, NJ, 08807 United States|
|Clinical Genomics Technologies Pty Ltd. 236 Fernwood Avenue Edison, NJ, 08837 United States|
|Clinical Genomics Technologies Pty Ltd. 2 Eden Park Drive Macquarie Park, NSW, 2113 Australia|
To request access, simply fill out the form below and we will contact you.